Table 2.
Association of Gli1 and Wnt2B protein expression with the clinicopathological parameters
| Clinicopathological features | Gli1 | Wnt2B | ||||
|---|---|---|---|---|---|---|
|
|
|
|||||
| high | low | P value | high | low | P value | |
|
|
|
|
|
|||
| N=55 | N=35 | N=17 | N=73 | |||
| Age (years) | ||||||
| <60 | 27 | 14 | 0.399 | 10 | 31 | 0.223 |
| ≥60 | 28 | 21 | 7 | 42 | ||
| Gender | ||||||
| Male | 32 | 25 | 0.204 | 12 | 45 | 0.491 |
| Female | 23 | 10 | 5 | 28 | ||
| Tumor location | ||||||
| Head | 35 | 26 | 0.292 | 11 | 50 | 0.763 |
| Body/rear | 20 | 9 | 6 | 23 | ||
| Tumor size (cm) | ||||||
| <4 | 20 | 14 | 0.729 | 6 | 28 | 0.815 |
| ≥4 | 35 | 21 | 11 | 45 | ||
| Tumor differentiation | ||||||
| Moderate/Well | 36 | 21 | 0.581 | 10 | 47 | 0.537 |
| poor | 13 | 10 | 6 | 17 | ||
| Lymph node metastasis | ||||||
| No | 27 | 25 | 0.036 | 10 | 42 | 0.923 |
| Yes | 28 | 10 | 7 | 31 | ||
| Perineural invasion | ||||||
| No | 6 | 14 | 0.065 | 3 | 17 | 0.045 |
| Yes | 19 | 15 | 14 | 20 | ||
| Miss | 30 | 6 | 0 | 36 | ||
| AJCC stage | ||||||
| I | 21 | 19 | 0.176 | 6 | 34 | 0.480 |
| II | 32 | 16 | 10 | 38 | ||